RBBP8 and prostate adenocarcinoma: Summarized data of the mean RBBP8 methylation ratio for each CpG site of BLCA-derived and control urine set #1 (including healthy, inflammatory, and benign samples) and set #2 (including set #1 samples plus testicular germ cell tumors (TGCT) and prostate adenocarcinoma (PRAD) samples) is shown in Fig. 6b.